Successful judgment-based steroid management of bevacizumab-induced acute kidney injury with suspected renal-limited thrombotic microangiopathy in a patient with colon cancer: a case report
- Urology & Nephrology Open Access Journal
-
Abdulrahman Bahatheq,1 Abdulaziz Mohammed Bajubair,1 Abdullah Alaa Farid,1 Rasha A.Alsulami,1 Zahra Kadhem Abdulnabi,1 Alaaeldin Helmy Darwish,1 Ahmed AkL1,2,3
PDF Full Text
Abstract
It is challenging to identify the aetiology of acute kidney injury in cancer patients since it can be multifactorial. Renal-limited thrombotic microangiopathy (rTMA) is a rare but recognized complication associated with certain antineoplastic therapies. Diagnosing rTMA in the context of bevacizumab therapy requires a high level of suspicion. In here, we report steroid responsive acute kidney injury associated with induction therapy with bevacizumab therapy.
Keywords
microangiopathy, bevacizumab therapy, kidney, angiogenesis
